Micro-X Past Earnings Performance
Past criteria checks 0/6
Micro-X's earnings have been declining at an average annual rate of -4.3%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 44.1% per year.
Key information
-4.3%
Earnings growth rate
27.7%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 44.1% |
| Return on equity | -145.6% |
| Net Margin | -95.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Micro-X Limited (ASX:MX1) Doing What It Can To Lift Shares
Mar 12
Sentiment Still Eluding Micro-X Limited (ASX:MX1)
Jul 14Is Micro-X (ASX:MX1) In A Good Position To Invest In Growth?
May 02Shareholders May Not Be So Generous With Micro-X Limited's (ASX:MX1) CEO Compensation And Here's Why
Nov 07We Think Micro-X (ASX:MX1) Needs To Drive Business Growth Carefully
Jul 07Here's Why We're Watching Micro-X's (ASX:MX1) Cash Burn Situation
Mar 01What We Learned About Micro-X's (ASX:MX1) CEO Pay
Jan 29What Kind Of Shareholders Hold The Majority In Micro-X Limited's (ASX:MX1) Shares?
Jan 08Have Insiders Been Buying Micro-X Limited (ASX:MX1) Shares?
Dec 18
Micro-X Limited's (ASX:MX1) Shift From Loss To Profit
Nov 27Revenue & Expenses BreakdownBeta
How Micro-X makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 15 | -15 | 19 | 3 |
| 30 Sep 23 | 15 | -13 | 19 | 2 |
| 30 Jun 23 | 15 | -11 | 19 | 0 |
| 31 Mar 23 | 15 | -11 | 19 | -3 |
| 31 Dec 22 | 15 | -12 | 18 | -3 |
| 30 Sep 22 | 12 | -15 | 18 | -2 |
| 30 Jun 22 | 9 | -17 | 18 | 0 |
| 31 Mar 22 | 6 | -18 | 17 | 0 |
| 31 Dec 21 | 4 | -19 | 17 | 0 |
| 30 Sep 21 | 4 | -17 | 14 | 0 |
| 30 Jun 21 | 4 | -15 | 12 | 0 |
| 31 Mar 21 | 5 | -13 | 10 | 0 |
| 31 Dec 20 | 6 | -11 | 8 | 0 |
| 30 Sep 20 | 5 | -10 | 8 | 0 |
| 30 Jun 20 | 4 | -10 | 8 | 0 |
| 31 Mar 20 | 3 | -9 | 8 | 0 |
| 31 Dec 19 | 2 | -8 | 7 | 0 |
| 30 Sep 19 | 2 | -9 | 7 | 0 |
| 30 Jun 19 | 2 | -10 | 7 | 0 |
| 31 Mar 19 | 2 | -14 | 7 | 0 |
| 31 Dec 18 | 2 | -18 | 6 | 0 |
| 30 Sep 18 | 2 | -17 | 6 | 0 |
| 30 Jun 18 | 2 | -17 | 6 | 0 |
| 31 Mar 18 | 1 | -14 | 5 | 0 |
| 31 Dec 17 | 1 | -11 | 5 | 0 |
| 30 Sep 17 | 1 | -12 | 4 | 0 |
| 30 Jun 17 | 1 | -13 | 4 | 0 |
| 31 Mar 17 | 1 | -13 | 4 | -4 |
| 31 Dec 16 | 1 | -13 | 3 | -8 |
| 30 Sep 16 | 1 | -12 | 3 | -4 |
| 30 Jun 16 | 1 | -11 | 2 | 0 |
| 31 Mar 16 | 1 | -12 | 1 | 6 |
| 31 Dec 15 | 0 | -13 | 1 | 13 |
| 30 Sep 15 | 0 | -11 | 1 | 10 |
| 30 Jun 15 | 0 | -10 | 0 | 7 |
| 30 Jun 14 | 0 | 0 | 0 | 0 |
Quality Earnings: MX1 is currently unprofitable.
Growing Profit Margin: MX1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MX1 is unprofitable, and losses have increased over the past 5 years at a rate of 4.3% per year.
Accelerating Growth: Unable to compare MX1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MX1 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: MX1 has a negative Return on Equity (-145.6%), as it is currently unprofitable.